Abstract

  TDDS i.e. transdermal drug delivery system has been an increased interest in the drug administration on diseased skin (topical delivery) as well as for systemic delivery of drugs. Econazole and Luliconazole is synthetic antifungal agent used for most kinds of fungal infections including superficial and invasive fungal infections. The formulated patches of the drug were evaluated for stability studies. Stability studies were carried out as per ICH guidelines at three different temperature and RH for 3 months for the optimized formulations of transdermal patches of econazole. The results indicates that the transdermal patches of econazole and luliconazole showing better results at 32°C ± 2°C/60% RH ± 5%.

Keywords:Transdermal Patches; Econazole; Luliconazole; Transdermal Patches

References

1. Michaels AS., et al. “Drug permeation through human skin: theory and in vitro experimental measurement”. AIChE Journal 5 (1975): 985-996.
2. Prausnitz MR and Langer R. “Transdermal drug delivery”. Nature Biotechnology 11 (2008): 1261-1268.
3. Devaux S., et al. “Adherence to topical treatment in psoriasis: a systematic literature review”. Journal of the European Academy of Dermatology and Venereology 3 (2012): 61-67.
4. Chen Y., et al. “Novel chemical permeation enhancers for transdermal drug delivery”. Asian Journal of Pharmaceutical Sciences2 (2014): 51-64.
5. Chien YW. “Transdermal drug delivery and delivery systems”. In: Novel drug delivery systems. Marcel Dekker, Inc., New York (1992): 301-380.
6. Degim IT. “New tools and approaches for predicting skin permeability”. Drug Discovery Today11-12 (2006): 517-523.
7. ICH guidelines, Stability testing of new drug substances and products (1993).

Citation

Citation: Gaurav Jain and Rakesh Patel. “Evaluation of Stability Studies on Transdermal Patches of Econazole and Luliconazole". Acta Scientific Medical Sciences 4.5 (2020): 60-63.

Copyright

Copyright: © 2020 Gaurav Jain and Rakesh Patel. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.